XXXVII Congreso SETH 2021.indd
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Guideline Therapeutics and COVID-19: living guideline
XXXVII Congreso SETH 2021.indd
XXXVII Congreso SETH 2021.indd
XXXVII Congreso SETH 2021.indd
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement | Science
Guideline Therapeutics and COVID-19: living guideline
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities | Journal of Medicinal Chemistry
MADS NØRGAARD – COPENHAGEN – MADS NØRGAARD - COPENHAGEN
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
NORTH SAILS 603154 - Parka
NAPAPIJRI Rainforest Winter - Jacket
Traditionell cowboy västerländsk läderjacka brun kappa med frans indiansk jacka mocka, Svart, XL : Amazon.se: Mode
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances
